Wettig Thane 4

What Happened

• Thane Wettig, CEO and director of Kyntra Bio, had 277 shares (disposed) withheld by the company on 2026-03-06 to satisfy a tax obligation related to restricted stock units. The withholding price was $6.84 per share, for a total value of $1,895.
• This was a tax-withholding transaction (routine), not an open-market sale or a purchase.

Key Details

• Transaction date: 2026-03-06; Filing date: 2026-03-10 (filed within the two-business-day window).
• Price per share: $6.84; Shares withheld/disposed: 277; Value: $1,895.
• Footnote: F1 — shares were withheld by the issuer to satisfy the reporting person’s tax obligation upon vesting of restricted stock units.
• Shares owned after the transaction: not specified in the provided filing.

Context

• Tax-withholding (F) transactions are common when RSUs vest; the company retains shares to cover required tax withholdings. These withholdings are routine and do not necessarily signal the insider’s view on the company’s prospects.